Mark Lowenberg

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease

Löwenberg, M., Vermeire, S., Mostafavi, N., Hoentjen, F., Franchimont, D., Bossuyt, P., Hindryckx, P., Rispens, T., de Vries, A., van der Woude, C. J., Berends, S., Ambarus, C. A., Mathot, R., Clasquin, E., Baert, F. & D'Haens, G., Oct 2019, In: Gastroenterology. 157, 4, p. 997-1006.e6

Research output: Contribution to journal › Article › Academic › peer-review

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

Danese, S., Vermeire, S., D'Haens, G., Panés, J., Dignass, A., Magro, F., Nazar, M., le Bars, M., Lahaye, M., Ni, L., Bravata, I., Lavie, F., Daperno, M., Lukáš, M., Armuzzi, A., Löwenberg, M., Gaya, D. R. & Peyrin-Biroulet, L., Apr 2022, In: lancet. Gastroenterology & hepatology. 7, 4, p. 294-306 13 p.

Research output: Contribution to journal › Article › Academic › peer-review

Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn’s disease; the Sensitivity to Change (STOC) study

Volkers, A., Bossuyt, P., de Jong, J., Pouillon, L., Gecse, K., Duijvestein, M., Ponsioen, C., D’Haens, G. & Löwenberg, M., 2022, In: Scandinavian journal of gastroenterology. 57, 4, p. 439-445 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

Implementation of ‘IBD-Specific Cognitive Behavioural Therapy’ for Patients with Inflammatory Bowel Diseases with Poor Mental Quality of Life, Anxiety and Depression

Bennebroek Evertsz’, F., Bockting, C. L., Braamse, A., van Dissel, M. N. M., Duijvestein, M., Kager, L. M., Kool, M., Löwenberg, M., Mares, W., Nieuwkerk, P., Sipkema, H. A., Young, Z. & Knoop, H., Jun 2024, In: Journal of clinical psychology in medical settings. 31, 2, p. 258-278 21 p.

Research output: Contribution to journal › Article › Academic › peer-review

Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes

Vermeire, S. V., Hanzel, J., Löwenberg, M., Ferrante, M., Bossuyt, P., Hoentjen, F., Franchimont, D., Palatka, K. R., Peeters, H., Mookhoek, A., de Hertogh, G., Molnár, T., van Moerkercke, W., Lobatón, T., Clasquin, E., Hulshoff, M. S. & on behalf of the LOVE-UC study group, 1 Apr 2024, In: Journal of Crohn's and Colitis. 18, 4, p. 540-547 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses

van den Dijssel, J., Duurland, M. C., Konijn, V. A. L., Kummer, L. Y. L., Hagen, R. R., Kuijper, L. H., Wieske, L., van Dam, K. P. J., Stalman, E. W., Steenhuis, M., Geerdes, D. M., Mok, J. Y., Kragten, A. H. M., Menage, C., Koets, L., Veldhuisen, B., Verstegen, N. J. M., van der Schoot, C. E., van Esch, W. J. E., D'Haens, G. R. AM., & 10 othersLöwenberg, M., Volkers, A. G., Rispens, T., Kuijpers, T. W., Eftimov, F., van Gisbergen, K. P. JM., van Ham, S. M., ten Brinke, A., van de Sandt, C. E. & T2B! immunity against SARS-CoV-2 study group, 1 Apr 2024, In: Journal of autoimmunity. 144, 103175.

Research output: Contribution to journal › Article › Academic › peer-review